tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

iRhythm price target raised to $175 from $160 at Truist

Truist analyst Richard Newitter raised the firm’s price target on iRhythm (IRTC) to $175 from $160 and keeps a Buy rating on the shares after its Q2 earnings beat. The firm expect iRhythm to see strength following a notable $13M revenue beat fueled by core business strength, Zio AT adoption, and progress with innovative channel partners, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1